FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164751335> ?p ?o ?g. }

• W3164751335 endingPage "e2111847" @default.
• W3164751335 startingPage "e2111847" @default.
• W3164751335 abstract "Randomized clinical trials (RCTs) are an essential method of evaluating health care interventions and a cornerstone for evidence-based health care. However, RCTs have become increasingly complex and costly, which is particularly challenging for independent investigator-initiated clinical trials (IICTs). IICTs have an essential role in clinical research, and it is important that efforts are made to ensure IICTs are adequately funded and are conducted cost-effectively.To examine the practices and attitudes of Swiss stakeholders regarding IICT funding acquisition and cost management.For this qualitative study, interviews were conducted in Switzerland between February and August 2020. The purposive sample comprised 48 stakeholders from 4 different groups: primary investigators (n = 27), funders and sponsors (n = 9), clinical trial support organizations (n = 6), and ethics committee members (n = 6).Practices and attitudes of stakeholders regarding IICT funding acquisition and cost management were assessed using individual semistructured qualitative interviews. Interviews were analyzed using conventional content analysis.After interviews with 48 IICT stakeholders (75% male presenting), these participants identified a systemic problem of IICTs being underfunded, which can lead to compromises being made regarding the quality and conduct of IICTs. Participants identified 2 overarching and interconnected groups of reasons why IICTs in Switzerland are regularly underfunded. First, it was reported that IICT budget estimations are often inaccurate because of poor planning and preparation, unforeseeable events, investigators intentionally underestimating budgets, and limited budget assessment and oversight. Second, with the exception of a specific IICT funding program by the Swiss National Science Foundation, it was reported that limited funding sources and unrealistic expectation of funders led to underlying challenges in getting IICTs fully funded. A number of measures that could help reduce the underfunding of IICTs were identified, including improving the support of investigators and IICTs, strengthening networking and guidance, harmonizing and simplifying bureaucracy, and increasing public funding of IICTs.This study highlights the inadequate expertise of Swiss stakeholders to correctly, systematically, and reproducibly calculate RCT budgets and the need for transparency on trial costs as well as training in budgeting practices. Limited financial resources for academic clinical research and issues regarding the professional planning and conduct of IICTs are persistent issues that many other countries also face." @default.
• W3164751335 created "2021-06-07" @default.
• W3164751335 creator A5019888759 @default.
• W3164751335 creator A5020702389 @default.
• W3164751335 creator A5050153683 @default.
• W3164751335 date "2021-06-02" @default.
• W3164751335 modified "2023-09-27" @default.
• W3164751335 title "Practices and Attitudes of Swiss Stakeholders Regarding Investigator-Initiated Clinical Trial Funding Acquisition and Cost Management" @default.
• W3164751335 cites W184765911 @default.
• W3164751335 cites W1975971094 @default.
• W3164751335 cites W1978821900 @default.
• W3164751335 cites W1981894901 @default.
• W3164751335 cites W1998951735 @default.
• W3164751335 cites W2008771899 @default.
• W3164751335 cites W2022238080 @default.
• W3164751335 cites W2031956916 @default.
• W3164751335 cites W2039234374 @default.
• W3164751335 cites W2052137692 @default.
• W3164751335 cites W2076160163 @default.
• W3164751335 cites W2085028749 @default.
• W3164751335 cites W2086805083 @default.
• W3164751335 cites W2101348497 @default.
• W3164751335 cites W2104961194 @default.
• W3164751335 cites W2106228247 @default.
• W3164751335 cites W2107059663 @default.
• W3164751335 cites W2109054675 @default.
• W3164751335 cites W2111256197 @default.
• W3164751335 cites W2134216627 @default.
• W3164751335 cites W2138664283 @default.
• W3164751335 cites W2142225512 @default.
• W3164751335 cites W2168435928 @default.
• W3164751335 cites W2170352413 @default.
• W3164751335 cites W2252448148 @default.
• W3164751335 cites W2263715254 @default.
• W3164751335 cites W2511045870 @default.
• W3164751335 cites W2607743218 @default.
• W3164751335 cites W2615117870 @default.
• W3164751335 cites W2735587480 @default.
• W3164751335 cites W2735754144 @default.
• W3164751335 cites W2790961431 @default.
• W3164751335 cites W2885447570 @default.
• W3164751335 cites W2889353251 @default.
• W3164751335 cites W2910047914 @default.
• W3164751335 cites W2962450311 @default.
• W3164751335 cites W2973459418 @default.
• W3164751335 cites W2993885906 @default.
• W3164751335 cites W2996617870 @default.
• W3164751335 cites W3035598337 @default.
• W3164751335 cites W3045499608 @default.
• W3164751335 cites W3049137268 @default.
• W3164751335 cites W3080113502 @default.
• W3164751335 cites W4241113490 @default.
• W3164751335 cites W4249999102 @default.
• W3164751335 cites W4253157783 @default.
• W3164751335 doi "https://doi.org/10.1001/jamanetworkopen.2021.11847" @default.
• W3164751335 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8173375" @default.
• W3164751335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34076698" @default.
• W3164751335 hasPublicationYear "2021" @default.
• W3164751335 type Work @default.
• W3164751335 sameAs 3164751335 @default.
• W3164751335 citedByCount "4" @default.
• W3164751335 countsByYear W31647513352021 @default.
• W3164751335 countsByYear W31647513352022 @default.
• W3164751335 crossrefType "journal-article" @default.
• W3164751335 hasAuthorship W3164751335A5019888759 @default.
• W3164751335 hasAuthorship W3164751335A5020702389 @default.
• W3164751335 hasAuthorship W3164751335A5050153683 @default.
• W3164751335 hasBestOaLocation W31647513351 @default.
• W3164751335 hasConcept C141071460 @default.
• W3164751335 hasConcept C142362112 @default.
• W3164751335 hasConcept C142724271 @default.
• W3164751335 hasConcept C144024400 @default.
• W3164751335 hasConcept C153349607 @default.
• W3164751335 hasConcept C15744967 @default.
• W3164751335 hasConcept C159110408 @default.
• W3164751335 hasConcept C160735492 @default.
• W3164751335 hasConcept C168563851 @default.
• W3164751335 hasConcept C17744445 @default.
• W3164751335 hasConcept C190248442 @default.
• W3164751335 hasConcept C199539241 @default.
• W3164751335 hasConcept C27415008 @default.
• W3164751335 hasConcept C2780616401 @default.
• W3164751335 hasConcept C36289849 @default.
• W3164751335 hasConcept C39549134 @default.
• W3164751335 hasConcept C509550671 @default.
• W3164751335 hasConcept C512399662 @default.
• W3164751335 hasConcept C535046627 @default.
• W3164751335 hasConcept C71924100 @default.
• W3164751335 hasConceptScore W3164751335C141071460 @default.
• W3164751335 hasConceptScore W3164751335C142362112 @default.
• W3164751335 hasConceptScore W3164751335C142724271 @default.
• W3164751335 hasConceptScore W3164751335C144024400 @default.
• W3164751335 hasConceptScore W3164751335C153349607 @default.
• W3164751335 hasConceptScore W3164751335C15744967 @default.
• W3164751335 hasConceptScore W3164751335C159110408 @default.
• W3164751335 hasConceptScore W3164751335C160735492 @default.
• W3164751335 hasConceptScore W3164751335C168563851 @default.
• W3164751335 hasConceptScore W3164751335C17744445 @default.

• next